SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Enterprises trades in fine fettle on BSE

10 Oct 2013 Evaluate

Piramal Enterprises is currently trading at Rs 570.00, up by 5.60 points or 0.99% from its previous closing of Rs 564.40 on the BSE.

The scrip opened at Rs 567.40 and has touched a high and low of Rs 574.00 and Rs 565.95 respectively. So far 1205 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 648.30 on 02-Sep-2013 and a 52 week low of Rs 395.00 on 06-Nov-2012.

Last one week high and low of the scrip stood at Rs 592.50 and Rs 562.00 respectively. The current market cap of the company is Rs 9836.96 crore.

The promoters holding in the company stood at 53.00% while Institutions and Non-Institutions held 30.03 % and 16.97 % respectively.

Piramal Enterprise’s Saridon, India's largest headache analgesic, has won two Gold Emvie Media Awards 2013 for ‘Best Media Strategy’ and ‘Best Media Innovation on Radio’. It is also honoured with ‘The People’s Choice Award’ for the top 10 advertisers in 2013 at The EMVIES 2013, instituted by the Advertising Club, India.

Saridon was also positioned as ‘The National Headache Reliever’ as it looked at various headache situations in media. The best movie reviewers in the industry used the Saridon and headache association to ‘Saridon rate’ a movie. With a total of 9680 interventions during stressful content and more than 50,000 seconds of Saridon associations on Media, Saridon received five stars for its performance in 2013.

Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×